We are live on
!
Find out more
VCM
Venor Capital Management Portfolio holdings
AUM
$58.9M
1-Year Est. Return
37.72%
This Fund
S&P 500
This Quarter
Est. Return
+7.6%
1 Year Est. Return
+37.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76.6M
AUM Growth
-$2.59M
(-3.3%)
Cap. Flow
-$5.2M
Cap. Flow
% of AUM
-6.79%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
4
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Option Care Health
OPCH
|
+$818K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CHAP
Chaparral Energy, Inc.
CHAP
|
+$3.51M |
| 2 |
CIVI
Civitas Resources
CIVI
|
+$1.02M |
| 3 |
Assured Guaranty
AGO
|
+$750K |
| 4 |
BRY
Berry Corp
BRY
|
+$737K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 43.78% |
| 2 | Healthcare | 41.89% |
| 3 | Financials | 14.33% |
Similar funds
RCI
MIMC
SAM
AEPIP
SCH
HM
LWP
BI
Venor Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Venor Capital Management held 6 positions worth $76.6M, down 3.3% from $79.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Venor Capital Management withdrew a net $5.2M in Q2 2019, reducing 4 holdings. Its largest reduction was Chaparral Energy, Inc., cutting an estimated $3.51M.
By sector, the portfolio is most concentrated in Energy at 44% of assets, down from 54% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Venor Capital Management added an estimated $818K to Option Care Health.
- Venor Capital Management added most to Option Care Health in Q2 2019, an estimated $818K increase.
- Venor Capital Management's biggest Q2 2019 reduction was Chaparral Energy, Inc., cutting an estimated $3.51M.
- Venor Capital Management's ten largest holdings make up 100% of its $76.6M portfolio in Q2 2019.
- Venor Capital Management opened 0 new positions and closed 0 in Q2 2019.
- Venor Capital Management's portfolio value fell 3.3% quarter-over-quarter to $76.6M.
Based on Venor Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.